logo
San Francisco ties clean needle distribution for drug users to treatment, counseling

San Francisco ties clean needle distribution for drug users to treatment, counseling

Yahoo03-04-2025
San Francisco Mayor Daniel Lurie, who won election in November on the pledge to crack down on the city's fentanyl crisis, announced a new public health policy Wednesday that will more forcefully push treatment on drug users seeking clean needles and other supplies tied to their addiction.
The new policy, to take effect April 30, marks a dramatic shift from the strategies San Francisco has used in recent years to encourage — but not pressure — illicit drug users into treatment, even as overdoses topped 800 in 2023. Though overdose numbers fell last year, preliminary data for 2025 show them creeping back up.
For years, San Francisco and other cities have fostered the growth of community programs that provide so-called harm reduction services. Such programs generally target homeless people struggling with addiction, sending out street workers to distribute sterile syringes and clean smoking kits — foil, pipes and straws, for example — with the aim of preventing transmissible diseases such as HIV and Hepatitis C. Many such programs also distribute Narcan, a medication that can rapidly reverse the effects of opioid overdoses.
The harm-reduction approach has staunch defenders, who say the strategy helps safeguard people with drug addictions until they are ready to commit to treatment. The strategy also has weary critics who say the notion of "meeting addicts where they are" has not proven effective enough at getting people to seek treatment or lowering death rates.
During a news conference at City Hall, Lurie said the days of San Francisco handing out drug supplies without connecting people to treatment "are over," and that the overdose crisis, fueled by fentanyl, mandates a more aggressive response.
"We have so much work to do in this city," Lurie said. "We are seeing people struggling with addiction. We are seeing people die of overdose. And we have to make a change."
Under the new policy, city staff and nonprofits that receive city funding are barred from handing out sterile syringes and other supplies unless they actively work to connect people with treatment and counseling. The policy prohibits workers from passing out smoking supplies in streets, parks and other public spaces, instead requiring such handouts be conducted indoors or at city-sanctioned locations. It does not change the rules around distributing clean syringes in public.
"We are really trying to get proactive here, instead of waiting, watching folks die," said Daniel Tsai, director of the San Francisco Public Health Department.
The tougher restrictions follow in the wake of the Trump administration's announcement last month that it was revoking billions in federal grants that help fund mental health and addiction services across the country. The prospect of major cuts in federal funding for community-level services is particularly worrisome for San Francisco leaders, who are facing a budget deficit of nearly $1 billion starting this year.
Lurie, who has generally avoided talking about Trump during his first months in office, said his administration would "focus on what we can control right now." In recent weeks, he has announced a series of policy shifts to move San Francisco away from what its critics — and many voters — perceive as a soft approach to deterring the open drug dealing and drug use that plague some neighborhoods, including downtown and the Tenderloin and South of Market districts.
Read more: San José mayor proposes jailing homeless people who repeatedly refuse shelter
Soon after taking office in January, Lurie worked with the Board of Supervisors to pass a measure giving his office more authority to bypass bureaucratic hurdles that have slowed expansion of shelter and treatment programs for homeless people, as well as more leeway to pursue private funding to finance those initiatives.
He is working to open a 24/7 "stabilization center" in the heart of the Tenderloin where police can drop off people who need medical care. He is also pushing forward with a campaign promise to open 1,500 more treatment beds.
Lurie's early efforts have alarmed some front-line street workers who say he is abandoning strategies that effectively prevent overdoses.
Tyler TerMeer, chief executive of the San Francisco AIDS Foundation, warned that the new policy could result in more people turning from smoking drugs to injecting them, raising the likelihood of people overdosing and contracting infectious diseases.
'San Francisco AIDS Foundation stands firm in our knowledge that providing people with the information and resources they need to take care of themselves, including safer-use supplies and treatment and counseling services, is best for the health of people who use substances," TerMeer said.
Lurie's office said the public health department will monitor overdose rates and the transmission of HIV and Hepatitis C "to ensure this policy aligns with overall public health goals."
Both Lurie and Tsai acknowledged the new approach will not be easy to implement. For one, the city does not have anywhere near enough treatment beds to accommodate all the people in need. And the rules stop short of forcing people into treatment. Still, Lurie said, San Francisco has to upend the status quo even as it expands capacity for treatment and interim housing.
"What we are doing is not working," Lurie said. "I am not going to sit by and not take action."
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
This story originally appeared in Los Angeles Times.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kennedy considering firing members of preventive services task force
Kennedy considering firing members of preventive services task force

NBC News

time11 hours ago

  • NBC News

Kennedy considering firing members of preventive services task force

Health Secretary Robert F. Kennedy Jr. is considering removing all 16 members of a highly influential advisory committee that offers guidance about preventive health services, such as cancer screenings, HIV prevention medications or tests for osteoporosis, according to two people familiar with the plan. The United States Preventive Services Task Force is a group of independent doctors, nurses and public health experts who volunteer to regularly review volumes of the latest scientific research about diseases, such as diabetes, obesity, heart disease and mental health, as well as mammograms for breast cancer. Health and Human Services' spokesperson Andrew Nixon said in an emailed statement Friday that 'no final decision has been made on how the USPSTF can better support HHS' mandate to Make America Healthy Again.' Earlier this month, Kennedy caused alarm among task force members after he abruptly postponed a scheduled meeting that was set to focus on heart disease and prevention. At the time, task force members weren't given a reason for the cancellation or whether the meeting would be rescheduled. Kennedy's plans were first reported Friday by The Wall Street Journal. The task force plays an important role in protecting access to screenings and tests because the Affordable Care Act, more commonly known as Obamacare, mandates that most private insurers provide the services that the group recommends to patients at no cost. The task force makes its recommendations using a grading scale. Under federal law, services that get an A or B grade but must be covered by insurance plans at no cost for patients. The advisory group has come under fire from conservative groups for some past decisions, including its 'A' recommendation to cover the HIV prevention pill, known as PrEP. The advisory group has come under fire from conservative groups for some past decisions, including its 'A' recommendation to cover the HIV prevention pill, known as PrEP. That recommendation led to a lawsuit from several Christian employers that ended up before the Supreme Court, where the justices decided 6-3 to uphold the Affordable Care Act provision that requires insurers to cover task force-recommended preventive services for free. However, the court agreed with the Trump administration that Kennedy has final say over decisions made by members of the task force because HHS has oversight over the group. As health secretary, he also has the authority to remove and replace members. Kennedy has made children's chronic disease a keystone of his position as the country's top health official. It's unclear which areas of health care Kennedy might target by shaking up the panel. In June, Kennedy fired all 17 members of the Advisory Committee on Immunization Practices — which makes recommendations to the Centers for Disease Control and Prevention about vaccines, including for children — and replaced them with eight new members. The new panel includes well-known vaccine critics.

A global HIV/AIDS program that saved millions of lives faces cuts under the Trump administration
A global HIV/AIDS program that saved millions of lives faces cuts under the Trump administration

NBC News

time13 hours ago

  • NBC News

A global HIV/AIDS program that saved millions of lives faces cuts under the Trump administration

WASHINGTON — The Trump administration is considering a dramatic cutback and eventual phasing out of the President's Emergency Plan for AIDS Relief (PEPFAR), the U.S. program to combat HIV/AIDS in developing countries that has been widely credited with saving 26 million lives since its inception in 2003, according to multiple congressional and administration officials. Created during the George W. Bush administration, PEPFAR was launched with star-power support from U2 frontman and advocate for developing countries, Bono, as well as the Bill and Melinda Gates Foundation and the World Bank. In the two decades since, it enjoyed strong bipartisan support in Congress. But as the Trump administration has sought to cut costs across the U.S. government, particularly for global aid programs, PEPFAR has come up on the chopping block. The administration initially proposed a cut of $400 million from next year's budget, but that funding was restored at the last minute by the Republican-led Senate last week, keeping it going in the short term. Four congressional aides told NBC News that the program was virtually frozen, along with most funding for USAID, in early February. Contracts with providers were put on hold and funding was reduced to what they called a 'trickle.' They said that most promised State Department waivers for critical care did not materialize, and that 51% of current PEPFAR appropriations were either terminated or were not functional. 'They're sitting on the money,' congressional officials said. 'We're not seeing it in the field.' According to the aides, in April, the State Department's then-director of the Office of Foreign Assistance, Peter Marocco, working with Elon Musk's DOGE team to dismantle foreign aid, briefed Congress that PEPFAR would refocus on maternal and child HIV transmission, excluding LGBT individuals and most preventative care that the program has done for decades. Earlier this month, a senior State Department official told reporters, 'The program was actually drowning in too much money, in some cases, you know, sort of going beyond its core mandate.' The official said, 'So instead, we're going to focus on that lifesaving care' and 'work with countries on self-reliance' to ensure there is not a gap in coverage. The senior official said that Secretary of State Marco Rubio is drawing a distinction between people who have HIV and need lifesaving direct treatment, and preventative care for sex workers as well as bisexual and gay men. The State Department official also said, 'It doesn't mean that the United States has to pay for every single thing around the world." "A lot of these countries, they've graduated to the point where their HIV rates are low enough and their economy is healthy enough that they can continue to pay for some of these things. We can get in, make positive change and then get out rather than paying forever so that every sex worker in Africa has PrEP," the official said, referring to HIV medication. Deputy Secretary of State for Management and Resources Michael Rigas testified to Congress last week that, overall, in the administration's budget request for the next fiscal year there is a 54% cut in PEPFAR's administrative, nondirect care funds. That is in addition to a 15% cut in the department's budget request for direct care in the same budget request. A global health staff of 700 people plus contractors in the field prior to President Donald Trump taking office has been reduced to 80 people after recent firings. Last month, White House budget director Russell Vought told a Senate committee, without providing evidence, that PEPFAR spent $9.3 million 'to advise Russian doctors on how to perform abortions and gender analysis.' Democratic Sen. Chris Coons of Delaware, a senior member of the Foreign Relations Committee and former chairman of the Africa Subcommittee, told NBC News that PEPFAR had always planned to get countries that had developed their own hospitals and health care systems, such as South Africa, to take over funding the program by 2030. According to Coons, that transition is already underway. But he and other critics of the current budget cuts said that it is not possible in low-income conflict zones, such as South Sudan, the Democratic Republic of Congo and Haiti, to replace the U.S program anytime soon. Still, according to a draft planning memo reported by The New York Times, the State Department would shut down U.S. support in Botswana, Namibia, South Africa and Vietnam within two years. Nations with high HIV infection rates, including Kenya, Zimbabwe and Angola, would get three to four years, the Times reported, while lower-income countries would get up to eight years under the proposal. NBC News has not viewed the draft plan and a State Department official told NBC News it has not been finalized. Dr. Robert Black, an epidemiologist at Johns Hopkins Bloomberg School of Public Health, who evaluated PEPFAR for Congress, told NBC News, 'I think two years for a number of countries, for many countries in Africa, would be too short,' adding, 'I just can't imagine two years would be an effective transition.' Black also said maintaining prevention is 'clearly important" and that withdrawing funding for prevention, which is contemplated under the Trump plan, would increase HIV rates and expand the burden. Rubio, who as a senator supported PEPFAR and other foreign aid, defended $20 billion in overall proposed budget cuts to the Senate Foreign Relations committee in May, citing 'duplicative, wasteful and ideologically driven programs.' Asked last week about the PEPFAR cuts, former Secretary of State Condoleezza Rice, who served in the Bush administration when PEPFAR was launched, told NBC News at the Aspen Security Forum, 'I do think PEPFAR is going to not only survive, I think it's going to be just fine. ... There will be some scaling back, and it's probably worth it to take a look at focusing on what we really need to focus on. We've become pretty dispersed and diffuse in the kinds of programs that we were running.' But, she added, 'what makes America different as a great power is that we have not led just with power, but we've also led with principle.' Later at the conference, Rice said launching PEPFAR was 'the proudest moment' in all of her government service. But she added that the U.S. also wants to build other countries' capacity and health care systems to sustain themselves. Former President Bush, in rare criticism of Trump's policies, praised fired foreign aid workers in a video last month. He told the State Department employees who had been fired, 'You've shown the great strength of America through your work, and that is our good heart.' Citing PEPFAR'S lifesaving work, Bush said, 'Is it in our interest that 25 million people who would have died, now live? I think it is. On behalf of a grateful nation, thank you for your hard work, and God bless you.' In a video, Bono told the foreign aid staff in verse, 'They called you crooks — when you were the best of us, there for the rest of us. And don't think any less of us, when politics makes a mess of us. It's not left-wing rhetoric to feed the hungry, heal the sick. If this isn't murder. I don't know what is.'

New Injectable Recommended by Europe for HIV Prevention
New Injectable Recommended by Europe for HIV Prevention

Medscape

time19 hours ago

  • Medscape

New Injectable Recommended by Europe for HIV Prevention

The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended granting a marketing authorization in the European Union (EU) for a twice-yearly injection to prevent HIV, in combination with safer sex practices. The EMA said Yeytuo (lenacapavir) was evaluated by the CHMP under an accelerated timeline due to its major public health interest in the EU and beyond. Yeytuo is anticipated to facilitate preexposure prophylaxis (PrEP) uptake and compliance as it only has to be administered twice a year, allowing patients to overcome several barriers associated with the daily oral pill for PrEP and other shorter-acting options. It also was recently approved by the US FDA. Thanks to advances in prevention and treatment, global HIV infection rates have been drastically reduced in recent years. However, in 2024, an estimated 1.3 million people became newly infected with HIV globally, including 160,000 new HIV infections in the European region. Moreover, in a recent report, the Joint United Nations Programme on HIV and AIDS (UNAIDS) predicted an additional 6 million new HIV infections and 4 million additional AIDS-related deaths worldwide between 2025 and 2029 resulting from the collapse of US funding. PrEP is a cornerstone of the global HIV response and is highly effective if taken properly. However, access to some PrEP medicines is limited, and adherence is often suboptimal due to various challenges, including the requirement to take a daily pill, stigma, and limited access to healthcare. Consequently, many people at risk for HIV acquisition remain underserved by existing PrEP options, highlighting the urgent need to develop — and distribute — innovative modalities. The CHMP's recommendation is based on the results of two randomized, double-blind, active-controlled, multinational trials. In the PURPOSE 1 trial, lenacapavir offered 100% protection against HIV among 5000 women aged 16-25 years in South Africa and Uganda. In the PURPOSE 2 trial, it offered almost complete protection among men and gender-diverse people aged ≥ 16 years who have sex with partners assigned male at birth in Argentina, Brazil, Mexico, Peru, South Africa, Thailand, and the US. In both trials, participants were randomly assigned in a 2:1 ratio to receive twice-yearly subcutaneous injections of lenacapavir or daily oral emtricitabine-tenofovir. Earlier this month, the World Health Organization (WHO) released new guidelines recommending the use of lenacapavir as an additional PrEP option for HIV prevention. It labeled lenacapavir as the next best thing to a vaccine and urged governments, donors, and global health partners to begin its rollout immediately within national combination HIV prevention programs. However, concerns have been raised about its price, with it currently being sold in the US for $28,218 per year. Its manufacturer, Gilead, announced last year that it had signed licensing agreements with six generic manufacturers to allow the production of low-cost versions of the drug for 120 high-incidence, resource-limited countries. The CHMP simultaneously reviewed the medicine for non-EU countries under a regulatory procedure called EU-Medicines for all (EU-M4All), which enables the EMA, in collaboration with the WHO, to more quickly make medicines available that address unmet medical needs, or are of major public health interest, in Europe and globally.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store